For ConsumerLab's most recent tests of meal replacement shakes, drinks and mixes, please see our Protein Powders, Shakes, and Meal Replacements Review
Mounting Evidence Links GLP-1 Drugs to Serious Health Issues For years, scientific studies have showed a link between the GLP-1 drugs and increased risks of serious gallbladder-related diseases and gastrointestinal issues, including: A 2016 study of over 70,000 patients found GLP-1 drugs associated with a significantly increased risk of bile duct and gallbladder disease compared to other oral antidiabetic drugs
Treatment duration varies by individual goals and response
Research demonstrates that women who lose weight through anti-obesity medications are frequently judged more harshly and perceived as having taken a shortcut to weight loss (Post and Persky, 2024)
those with personal/family history of thyroid cancer or pancreatitis should avoid GLP-1 agonists
Nutrients , 10 (12), 1876